Price$9.90-1.11 (-10.08%)
02:45 PM06:45 PM
News · 26 weeks25+20%
2025-12-072026-05-31
Mix1790d
- SEC Filings12(71%)
- Earnings4(24%)
- Insider1(6%)
Latest news
25 items- SECP3 Health Partners Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - P3 Health Partners Inc. (0001832511) (Filer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Pedersen Leif Elliott4 - P3 Health Partners Inc. (0001832511) (Issuer)
- SECP3 Health Partners Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits8-K - P3 Health Partners Inc. (0001832511) (Filer)
- SECSEC Form 10-Q filed by P3 Health Partners Inc.10-Q - P3 Health Partners Inc. (0001832511) (Filer)
- SECP3 Health Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - P3 Health Partners Inc. (0001832511) (Filer)
- PRP3 Health Partners Announces First Quarter 2026 ResultsRaises Full-Year 2026 Adjusted EBITDA Guidance Management to Host Conference Call and Webcast May 14, 2026 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2026. "Q1 represents a meaningful turning point for the business. The $26 million of adjusted EBITDA we delivered this quarter reflects the cumulative impact of two years of deliberate work, including contract restructuring, network concentration, and operational redesign. Based on the strength of Q1 and our confidence in the underlying trajectory, we are
- SECSEC Form DEFA14A filed by P3 Health Partners Inc.DEFA14A - P3 Health Partners Inc. (0001832511) (Filer)
- SECSEC Form DEF 14A filed by P3 Health Partners Inc.DEF 14A - P3 Health Partners Inc. (0001832511) (Filer)
- SECP3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - P3 Health Partners Inc. (0001832511) (Filer)
- SECSEC Form PRE 14A filed by P3 Health Partners Inc.PRE 14A - P3 Health Partners Inc. (0001832511) (Filer)
- PRP3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference CallP3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2026 on Thursday, May 14, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter 2026 Earnings Conference Call Date & Time May 14, 2026, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 International 1-412-317-0692 Ask to be joined into the P3 Health Partners call
- SECSEC Form S-8 filed by P3 Health Partners Inc.S-8 - P3 Health Partners Inc. (0001832511) (Filer)
- SECSEC Form 10-K filed by P3 Health Partners Inc.10-K - P3 Health Partners Inc. (0001832511) (Filer)
- SECP3 Health Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - P3 Health Partners Inc. (0001832511) (Filer)
- PRP3 Health Partners Announces Fourth Quarter and Full Year 2025 ResultsProviding 2026 Guidance, Indicating a $10 Million Adjusted EBITDA Midpoint Management to Host Conference Call and Webcast March 26, 2026 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2025, and provided 2026 guidance. "2025 was a year of meaningful progress in repositioning the business. We strengthened our contract economics, improved provider alignment, and built a more disciplined operating foundation. With that work in place, we enter 2026 with a clear path to profitability and approxi
- SECP3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - P3 Health Partners Inc. (0001832511) (Filer)
- PRP3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference CallP3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for fourth quarter and full year 2025 on Thursday, March 26, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter and Full Year 2025 Earnings Conference Call Date & Time March 26, 2026, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 International 1-412-317-0692 Ask to be joined into t
- SECP3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - P3 Health Partners Inc. (0001832511) (Filer)
- INSIDERAmendment: Director Wasson Gregory D was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)4/A - P3 Health Partners Inc. (0001832511) (Issuer)
- INSIDERAmendment: Director Tolan Mary A was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)4/A - P3 Health Partners Inc. (0001832511) (Issuer)
- INSIDERAmendment: Director Leisure Lawrence B. was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)4/A - P3 Health Partners Inc. (0001832511) (Issuer)
- INSIDERAmendment: Director Kazarian Gregory N. was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)4/A - P3 Health Partners Inc. (0001832511) (Issuer)
- INSIDERAmendment: Director Thierer Mark was granted 4,000 units of Class A Common Stock, increasing direct ownership by 46% to 12,662 units (SEC Form 4)4/A - P3 Health Partners Inc. (0001832511) (Issuer)
- INSIDERAmendment: Director Price Thomas Edmunds was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)4/A - P3 Health Partners Inc. (0001832511) (Issuer)
- INSIDERAmendment: Director Park Jeffrey G was granted 2,000 units of Class A Common Stock, increasing direct ownership by 46% to 6,331 units (SEC Form 4)4/A - P3 Health Partners Inc. (0001832511) (Issuer)
PIII FAQ
7 questionsWhat does P3 Health Partners Inc. do?
P3 Health Partners Inc. provides primary health care services. The company offers clinical operations and population health management services, as well as provides senior wellness centers. The company is based in Henderson, Nevada.Where does PIII stock trade?
P3 Health Partners Inc. (PIII) is listed on NASDAQ.What sector and industry is PIII in?
P3 Health Partners Inc. operates in the Health Care sector, Medical/Nursing Services industry.When did P3 Health Partners Inc. go public?
P3 Health Partners Inc. (PIII) completed its IPO in 2021.What are analysts saying about PIII?
P3 Health Partners Inc. has had 5 recent analyst actions on file. The most recent action was from Lake Street: Buy with a $2000.00 price target on 2025-08-28. Recent price targets range from $500.00 to $2000.00.What companies are similar to PIII?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), HIMS (Hims & Hers Health Inc.), CHE (Chemed Corp), AMED (Amedisys Inc), LHCG (LHC Group). Compare PIII side-by-side with any of them on Quantisnow.How can I track PIII on Quantisnow?
Quantisnow aggregates P3 Health Partners Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PIII to receive live email and push alerts on every new disclosure.